nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—systemic scleroderma	0.478	1	CrCtD
Leucovorin—Pemetrexed—Methotrexate—systemic scleroderma	0.0633	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—systemic scleroderma	0.0633	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—systemic scleroderma	0.0633	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—systemic scleroderma	0.0633	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—systemic scleroderma	0.0633	0.2	CrCrCtD
Leucovorin—TYMS—Methotrexate—systemic scleroderma	0.0574	0.365	CbGbCtD
Leucovorin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0337	0.215	CbGbCtD
Leucovorin—ABCC3—Methotrexate—systemic scleroderma	0.0297	0.189	CbGbCtD
Leucovorin—ABCC4—Methotrexate—systemic scleroderma	0.0227	0.145	CbGbCtD
Leucovorin—ABCC2—Methotrexate—systemic scleroderma	0.0135	0.0861	CbGbCtD
Leucovorin—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.000158	0.117	CbGdCrCtD
Leucovorin—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.000156	0.115	CbGdCrCtD
Leucovorin—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.000154	0.114	CbGdCrCtD
Leucovorin—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00015	0.111	CbGdCrCtD
Leucovorin—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.000142	0.105	CbGdCrCtD
Leucovorin—Leukopenia—Leflunomide—systemic scleroderma	0.000138	0.00295	CcSEcCtD
Leucovorin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000138	0.00295	CcSEcCtD
Leucovorin—Body temperature increased—Mometasone—systemic scleroderma	0.000138	0.00294	CcSEcCtD
Leucovorin—Abdominal pain—Mometasone—systemic scleroderma	0.000138	0.00294	CcSEcCtD
Leucovorin—Discomfort—Azathioprine—systemic scleroderma	0.000138	0.00294	CcSEcCtD
Leucovorin—Chills—Lisinopril—systemic scleroderma	0.000137	0.00292	CcSEcCtD
Leucovorin—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000137	0.00292	CcSEcCtD
Leucovorin—Dyspnoea—Captopril—systemic scleroderma	0.000136	0.00291	CcSEcCtD
Leucovorin—Alopecia—Lisinopril—systemic scleroderma	0.000135	0.00288	CcSEcCtD
Leucovorin—Dyspepsia—Captopril—systemic scleroderma	0.000135	0.00287	CcSEcCtD
Leucovorin—Lethargy—Prednisone—systemic scleroderma	0.000134	0.00285	CcSEcCtD
Leucovorin—Dizziness—Pentoxifylline—systemic scleroderma	0.000133	0.00285	CcSEcCtD
Leucovorin—Decreased appetite—Captopril—systemic scleroderma	0.000133	0.00284	CcSEcCtD
Leucovorin—Malaise—Mycophenolic acid—systemic scleroderma	0.000133	0.00284	CcSEcCtD
Leucovorin—Erythema—Lisinopril—systemic scleroderma	0.000133	0.00283	CcSEcCtD
Leucovorin—Infection—Azathioprine—systemic scleroderma	0.000133	0.00283	CcSEcCtD
Leucovorin—Syncope—Mycophenolic acid—systemic scleroderma	0.000132	0.00282	CcSEcCtD
Leucovorin—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000132	0.00282	CcSEcCtD
Leucovorin—Fatigue—Captopril—systemic scleroderma	0.000132	0.00282	CcSEcCtD
Leucovorin—Constipation—Captopril—systemic scleroderma	0.000131	0.00279	CcSEcCtD
Leucovorin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000131	0.00279	CcSEcCtD
Leucovorin—Dysgeusia—Lisinopril—systemic scleroderma	0.00013	0.00278	CcSEcCtD
Leucovorin—Discomfort—Leflunomide—systemic scleroderma	0.00013	0.00277	CcSEcCtD
Leucovorin—Skin disorder—Azathioprine—systemic scleroderma	0.00013	0.00277	CcSEcCtD
Leucovorin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00013	0.00277	CcSEcCtD
Leucovorin—Vomiting—Pentoxifylline—systemic scleroderma	0.000128	0.00274	CcSEcCtD
Leucovorin—Convulsion—Mycophenolic acid—systemic scleroderma	0.000128	0.00273	CcSEcCtD
Leucovorin—Rash—Pentoxifylline—systemic scleroderma	0.000127	0.00272	CcSEcCtD
Leucovorin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000127	0.00271	CcSEcCtD
Leucovorin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000126	0.00269	CcSEcCtD
Leucovorin—Feeling abnormal—Captopril—systemic scleroderma	0.000126	0.00269	CcSEcCtD
Leucovorin—Infection—Leflunomide—systemic scleroderma	0.000125	0.00267	CcSEcCtD
Leucovorin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000125	0.00267	CcSEcCtD
Leucovorin—Asthenia—Mometasone—systemic scleroderma	0.000125	0.00267	CcSEcCtD
Leucovorin—TYMS—Budesonide—Mometasone—systemic scleroderma	0.000124	0.0922	CbGdCrCtD
Leucovorin—Discomfort—Mycophenolic acid—systemic scleroderma	0.000124	0.00265	CcSEcCtD
Leucovorin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000123	0.00264	CcSEcCtD
Leucovorin—Pruritus—Mometasone—systemic scleroderma	0.000123	0.00263	CcSEcCtD
Leucovorin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000123	0.00263	CcSEcCtD
Leucovorin—Skin disorder—Leflunomide—systemic scleroderma	0.000122	0.00261	CcSEcCtD
Leucovorin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000121	0.00259	CcSEcCtD
Leucovorin—Abdominal pain—Captopril—systemic scleroderma	0.000121	0.00258	CcSEcCtD
Leucovorin—Body temperature increased—Captopril—systemic scleroderma	0.000121	0.00258	CcSEcCtD
Leucovorin—Anorexia—Leflunomide—systemic scleroderma	0.00012	0.00257	CcSEcCtD
Leucovorin—Nausea—Pentoxifylline—systemic scleroderma	0.00012	0.00256	CcSEcCtD
Leucovorin—Chills—Mycophenolate mofetil—systemic scleroderma	0.00012	0.00256	CcSEcCtD
Leucovorin—Malaise—Lisinopril—systemic scleroderma	0.00012	0.00256	CcSEcCtD
Leucovorin—Infection—Mycophenolic acid—systemic scleroderma	0.000119	0.00255	CcSEcCtD
Leucovorin—Diarrhoea—Mometasone—systemic scleroderma	0.000119	0.00254	CcSEcCtD
Leucovorin—Syncope—Lisinopril—systemic scleroderma	0.000119	0.00254	CcSEcCtD
Leucovorin—Leukopenia—Lisinopril—systemic scleroderma	0.000119	0.00254	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—systemic scleroderma	0.000118	0.00253	CcSEcCtD
Leucovorin—Shock—Mycophenolic acid—systemic scleroderma	0.000118	0.00253	CcSEcCtD
Leucovorin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00252	CcSEcCtD
Leucovorin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000118	0.00251	CcSEcCtD
Leucovorin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000117	0.00249	CcSEcCtD
Leucovorin—Loss of consciousness—Lisinopril—systemic scleroderma	0.000117	0.00249	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000115	0.00246	CcSEcCtD
Leucovorin—Anorexia—Mycophenolic acid—systemic scleroderma	0.000115	0.00245	CcSEcCtD
Leucovorin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000114	0.00243	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000113	0.00241	CcSEcCtD
Leucovorin—Dyspnoea—Leflunomide—systemic scleroderma	0.000112	0.0024	CcSEcCtD
Leucovorin—Discomfort—Lisinopril—systemic scleroderma	0.000112	0.00238	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—systemic scleroderma	0.000112	0.00238	CcSEcCtD
Leucovorin—Dyspepsia—Leflunomide—systemic scleroderma	0.000111	0.00237	CcSEcCtD
Leucovorin—Vomiting—Mometasone—systemic scleroderma	0.000111	0.00236	CcSEcCtD
Leucovorin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00011	0.00235	CcSEcCtD
Leucovorin—Rash—Mometasone—systemic scleroderma	0.00011	0.00234	CcSEcCtD
Leucovorin—Asthenia—Captopril—systemic scleroderma	0.00011	0.00234	CcSEcCtD
Leucovorin—Dermatitis—Mometasone—systemic scleroderma	0.00011	0.00234	CcSEcCtD
Leucovorin—Decreased appetite—Leflunomide—systemic scleroderma	0.00011	0.00234	CcSEcCtD
Leucovorin—Confusional state—Lisinopril—systemic scleroderma	0.000109	0.00233	CcSEcCtD
Leucovorin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000109	0.00233	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000109	0.00232	CcSEcCtD
Leucovorin—Fatigue—Leflunomide—systemic scleroderma	0.000109	0.00232	CcSEcCtD
Leucovorin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000108	0.00231	CcSEcCtD
Leucovorin—Pruritus—Captopril—systemic scleroderma	0.000108	0.00231	CcSEcCtD
Leucovorin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000108	0.0023	CcSEcCtD
Leucovorin—Constipation—Leflunomide—systemic scleroderma	0.000108	0.0023	CcSEcCtD
Leucovorin—Infection—Lisinopril—systemic scleroderma	0.000108	0.0023	CcSEcCtD
Leucovorin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000107	0.00229	CcSEcCtD
Leucovorin—Shock—Lisinopril—systemic scleroderma	0.000107	0.00228	CcSEcCtD
Leucovorin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000106	0.00226	CcSEcCtD
Leucovorin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000106	0.00226	CcSEcCtD
Leucovorin—Body temperature increased—Azathioprine—systemic scleroderma	0.000106	0.00225	CcSEcCtD
Leucovorin—Abdominal pain—Azathioprine—systemic scleroderma	0.000106	0.00225	CcSEcCtD
Leucovorin—Skin disorder—Lisinopril—systemic scleroderma	0.000105	0.00225	CcSEcCtD
Leucovorin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00224	CcSEcCtD
Leucovorin—Diarrhoea—Captopril—systemic scleroderma	0.000105	0.00223	CcSEcCtD
Leucovorin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000105	0.00223	CcSEcCtD
Leucovorin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00223	CcSEcCtD
Leucovorin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00222	CcSEcCtD
Leucovorin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000104	0.00222	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000104	0.00222	CcSEcCtD
Leucovorin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000104	0.00221	CcSEcCtD
Leucovorin—Nausea—Mometasone—systemic scleroderma	0.000103	0.00221	CcSEcCtD
Leucovorin—Anorexia—Lisinopril—systemic scleroderma	0.000103	0.0022	CcSEcCtD
Leucovorin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000103	0.0022	CcSEcCtD
Leucovorin—Constipation—Mycophenolic acid—systemic scleroderma	0.000103	0.0022	CcSEcCtD
Leucovorin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00218	CcSEcCtD
Leucovorin—Dizziness—Captopril—systemic scleroderma	0.000101	0.00216	CcSEcCtD
Leucovorin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00215	CcSEcCtD
Leucovorin—Urticaria—Leflunomide—systemic scleroderma	0.0001	0.00214	CcSEcCtD
Leucovorin—Body temperature increased—Leflunomide—systemic scleroderma	9.97e-05	0.00213	CcSEcCtD
Leucovorin—Abdominal pain—Leflunomide—systemic scleroderma	9.97e-05	0.00213	CcSEcCtD
Leucovorin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	9.91e-05	0.00212	CcSEcCtD
Leucovorin—Neuropathy peripheral—Prednisone—systemic scleroderma	9.89e-05	0.00211	CcSEcCtD
Leucovorin—Hypersensitivity—Azathioprine—systemic scleroderma	9.83e-05	0.0021	CcSEcCtD
Leucovorin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	9.83e-05	0.0021	CcSEcCtD
Leucovorin—Discomfort—Mycophenolate mofetil—systemic scleroderma	9.78e-05	0.00209	CcSEcCtD
Leucovorin—Vomiting—Captopril—systemic scleroderma	9.72e-05	0.00208	CcSEcCtD
Leucovorin—Dyspnoea—Lisinopril—systemic scleroderma	9.66e-05	0.00206	CcSEcCtD
Leucovorin—Rash—Captopril—systemic scleroderma	9.64e-05	0.00206	CcSEcCtD
Leucovorin—Dermatitis—Captopril—systemic scleroderma	9.64e-05	0.00206	CcSEcCtD
Leucovorin—Confusional state—Mycophenolate mofetil—systemic scleroderma	9.57e-05	0.00204	CcSEcCtD
Leucovorin—Dyspepsia—Lisinopril—systemic scleroderma	9.53e-05	0.00204	CcSEcCtD
Leucovorin—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.51e-05	0.00203	CcSEcCtD
Leucovorin—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.51e-05	0.00203	CcSEcCtD
Leucovorin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	9.49e-05	0.00203	CcSEcCtD
Leucovorin—Infection—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.00201	CcSEcCtD
Leucovorin—Decreased appetite—Lisinopril—systemic scleroderma	9.42e-05	0.00201	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	9.35e-05	0.002	CcSEcCtD
Leucovorin—Fatigue—Lisinopril—systemic scleroderma	9.34e-05	0.00199	CcSEcCtD
Leucovorin—Shock—Mycophenolate mofetil—systemic scleroderma	9.34e-05	0.00199	CcSEcCtD
Leucovorin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.29e-05	0.00198	CcSEcCtD
Leucovorin—Hypersensitivity—Leflunomide—systemic scleroderma	9.29e-05	0.00198	CcSEcCtD
Leucovorin—Constipation—Lisinopril—systemic scleroderma	9.26e-05	0.00198	CcSEcCtD
Leucovorin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	9.22e-05	0.00197	CcSEcCtD
Leucovorin—Diarrhoea—Azathioprine—systemic scleroderma	9.13e-05	0.00195	CcSEcCtD
Leucovorin—Nausea—Captopril—systemic scleroderma	9.09e-05	0.00194	CcSEcCtD
Leucovorin—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.05e-05	0.00193	CcSEcCtD
Leucovorin—Asthenia—Leflunomide—systemic scleroderma	9.04e-05	0.00193	CcSEcCtD
Leucovorin—Feeling abnormal—Lisinopril—systemic scleroderma	8.93e-05	0.00191	CcSEcCtD
Leucovorin—Pruritus—Leflunomide—systemic scleroderma	8.92e-05	0.0019	CcSEcCtD
Leucovorin—Gastrointestinal pain—Lisinopril—systemic scleroderma	8.86e-05	0.00189	CcSEcCtD
Leucovorin—Dizziness—Azathioprine—systemic scleroderma	8.83e-05	0.00188	CcSEcCtD
Leucovorin—Asthenia—Mycophenolic acid—systemic scleroderma	8.63e-05	0.00184	CcSEcCtD
Leucovorin—Diarrhoea—Leflunomide—systemic scleroderma	8.63e-05	0.00184	CcSEcCtD
Leucovorin—Urticaria—Lisinopril—systemic scleroderma	8.61e-05	0.00184	CcSEcCtD
Leucovorin—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	8.59e-05	0.0637	CbGdCrCtD
Leucovorin—Abdominal pain—Lisinopril—systemic scleroderma	8.56e-05	0.00183	CcSEcCtD
Leucovorin—Body temperature increased—Lisinopril—systemic scleroderma	8.56e-05	0.00183	CcSEcCtD
Leucovorin—Pruritus—Mycophenolic acid—systemic scleroderma	8.51e-05	0.00182	CcSEcCtD
Leucovorin—Vomiting—Azathioprine—systemic scleroderma	8.49e-05	0.00181	CcSEcCtD
Leucovorin—TYMS—Flunisolide—Prednisone—systemic scleroderma	8.48e-05	0.0629	CbGdCrCtD
Leucovorin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.00181	CcSEcCtD
Leucovorin—Rash—Azathioprine—systemic scleroderma	8.42e-05	0.0018	CcSEcCtD
Leucovorin—Dermatitis—Azathioprine—systemic scleroderma	8.41e-05	0.0018	CcSEcCtD
Leucovorin—TYMS—Triamcinolone—Prednisone—systemic scleroderma	8.39e-05	0.0622	CbGdCrCtD
Leucovorin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	8.35e-05	0.00178	CcSEcCtD
Leucovorin—Dizziness—Leflunomide—systemic scleroderma	8.34e-05	0.00178	CcSEcCtD
Leucovorin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.25e-05	0.00176	CcSEcCtD
Leucovorin—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.23e-05	0.00176	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—systemic scleroderma	8.22e-05	0.00175	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	8.19e-05	0.00175	CcSEcCtD
Leucovorin—Constipation—Mycophenolate mofetil—systemic scleroderma	8.12e-05	0.00173	CcSEcCtD
Leucovorin—Vomiting—Leflunomide—systemic scleroderma	8.02e-05	0.00171	CcSEcCtD
Leucovorin—Alopecia—Prednisone—systemic scleroderma	8e-05	0.00171	CcSEcCtD
Leucovorin—Hypersensitivity—Lisinopril—systemic scleroderma	7.98e-05	0.0017	CcSEcCtD
Leucovorin—Dizziness—Mycophenolic acid—systemic scleroderma	7.95e-05	0.0017	CcSEcCtD
Leucovorin—Rash—Leflunomide—systemic scleroderma	7.95e-05	0.0017	CcSEcCtD
Leucovorin—Dermatitis—Leflunomide—systemic scleroderma	7.94e-05	0.0017	CcSEcCtD
Leucovorin—Nausea—Azathioprine—systemic scleroderma	7.93e-05	0.00169	CcSEcCtD
Leucovorin—Erythema—Prednisone—systemic scleroderma	7.88e-05	0.00168	CcSEcCtD
Leucovorin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	7.82e-05	0.00167	CcSEcCtD
Leucovorin—Asthenia—Lisinopril—systemic scleroderma	7.77e-05	0.00166	CcSEcCtD
Leucovorin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	7.76e-05	0.00166	CcSEcCtD
Leucovorin—TYMS—Diflorasone—Prednisone—systemic scleroderma	7.74e-05	0.0574	CbGdCrCtD
Leucovorin—Pruritus—Lisinopril—systemic scleroderma	7.66e-05	0.00164	CcSEcCtD
Leucovorin—Vomiting—Mycophenolic acid—systemic scleroderma	7.65e-05	0.00163	CcSEcCtD
Leucovorin—Rash—Mycophenolic acid—systemic scleroderma	7.58e-05	0.00162	CcSEcCtD
Leucovorin—Dermatitis—Mycophenolic acid—systemic scleroderma	7.58e-05	0.00162	CcSEcCtD
Leucovorin—Urticaria—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.00161	CcSEcCtD
Leucovorin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.5e-05	0.0016	CcSEcCtD
Leucovorin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.5e-05	0.0016	CcSEcCtD
Leucovorin—Nausea—Leflunomide—systemic scleroderma	7.49e-05	0.0016	CcSEcCtD
Leucovorin—Diarrhoea—Lisinopril—systemic scleroderma	7.41e-05	0.00158	CcSEcCtD
Leucovorin—Ill-defined disorder—Prednisone—systemic scleroderma	7.31e-05	0.00156	CcSEcCtD
Leucovorin—Dizziness—Lisinopril—systemic scleroderma	7.16e-05	0.00153	CcSEcCtD
Leucovorin—Nausea—Mycophenolic acid—systemic scleroderma	7.14e-05	0.00153	CcSEcCtD
Leucovorin—Malaise—Prednisone—systemic scleroderma	7.11e-05	0.00152	CcSEcCtD
Leucovorin—Syncope—Prednisone—systemic scleroderma	7.07e-05	0.00151	CcSEcCtD
Leucovorin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.00149	CcSEcCtD
Leucovorin—Loss of consciousness—Prednisone—systemic scleroderma	6.93e-05	0.00148	CcSEcCtD
Leucovorin—Vomiting—Lisinopril—systemic scleroderma	6.89e-05	0.00147	CcSEcCtD
Leucovorin—Rash—Lisinopril—systemic scleroderma	6.83e-05	0.00146	CcSEcCtD
Leucovorin—Convulsion—Prednisone—systemic scleroderma	6.83e-05	0.00146	CcSEcCtD
Leucovorin—Dermatitis—Lisinopril—systemic scleroderma	6.82e-05	0.00146	CcSEcCtD
Leucovorin—Asthenia—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.00145	CcSEcCtD
Leucovorin—Chills—Methotrexate—systemic scleroderma	6.79e-05	0.00145	CcSEcCtD
Leucovorin—TYMS—Budesonide—Prednisone—systemic scleroderma	6.78e-05	0.0503	CbGdCrCtD
Leucovorin—Pruritus—Mycophenolate mofetil—systemic scleroderma	6.71e-05	0.00143	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—systemic scleroderma	6.69e-05	0.00143	CcSEcCtD
Leucovorin—Discomfort—Prednisone—systemic scleroderma	6.63e-05	0.00142	CcSEcCtD
Leucovorin—Erythema—Methotrexate—systemic scleroderma	6.59e-05	0.00141	CcSEcCtD
Leucovorin—TYMS—Danazol—Prednisone—systemic scleroderma	6.5e-05	0.0482	CbGdCrCtD
Leucovorin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.49e-05	0.00139	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—systemic scleroderma	6.45e-05	0.00138	CcSEcCtD
Leucovorin—Nausea—Lisinopril—systemic scleroderma	6.43e-05	0.00137	CcSEcCtD
Leucovorin—Anaphylactic shock—Prednisone—systemic scleroderma	6.43e-05	0.00137	CcSEcCtD
Leucovorin—Infection—Prednisone—systemic scleroderma	6.39e-05	0.00136	CcSEcCtD
Leucovorin—Shock—Prednisone—systemic scleroderma	6.33e-05	0.00135	CcSEcCtD
Leucovorin—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.28e-05	0.00134	CcSEcCtD
Leucovorin—Skin disorder—Prednisone—systemic scleroderma	6.25e-05	0.00133	CcSEcCtD
Leucovorin—Anorexia—Prednisone—systemic scleroderma	6.13e-05	0.00131	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—systemic scleroderma	6.11e-05	0.00131	CcSEcCtD
Leucovorin—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.03e-05	0.00129	CcSEcCtD
Leucovorin—Rash—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.00128	CcSEcCtD
Leucovorin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.00128	CcSEcCtD
Leucovorin—Malaise—Methotrexate—systemic scleroderma	5.94e-05	0.00127	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—systemic scleroderma	5.9e-05	0.00126	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—systemic scleroderma	5.71e-05	0.00122	CcSEcCtD
Leucovorin—Dyspepsia—Prednisone—systemic scleroderma	5.66e-05	0.00121	CcSEcCtD
Leucovorin—Nausea—Mycophenolate mofetil—systemic scleroderma	5.64e-05	0.0012	CcSEcCtD
Leucovorin—Decreased appetite—Prednisone—systemic scleroderma	5.59e-05	0.00119	CcSEcCtD
Leucovorin—Fatigue—Prednisone—systemic scleroderma	5.55e-05	0.00118	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—systemic scleroderma	5.54e-05	0.00118	CcSEcCtD
Leucovorin—Constipation—Prednisone—systemic scleroderma	5.5e-05	0.00117	CcSEcCtD
Leucovorin—Confusional state—Methotrexate—systemic scleroderma	5.42e-05	0.00116	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—systemic scleroderma	5.38e-05	0.00115	CcSEcCtD
Leucovorin—Infection—Methotrexate—systemic scleroderma	5.34e-05	0.00114	CcSEcCtD
Leucovorin—Feeling abnormal—Prednisone—systemic scleroderma	5.3e-05	0.00113	CcSEcCtD
Leucovorin—Thrombocytopenia—Methotrexate—systemic scleroderma	5.26e-05	0.00112	CcSEcCtD
Leucovorin—Gastrointestinal pain—Prednisone—systemic scleroderma	5.26e-05	0.00112	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—systemic scleroderma	5.22e-05	0.00112	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—systemic scleroderma	5.12e-05	0.00109	CcSEcCtD
Leucovorin—Urticaria—Prednisone—systemic scleroderma	5.11e-05	0.00109	CcSEcCtD
Leucovorin—Body temperature increased—Prednisone—systemic scleroderma	5.09e-05	0.00109	CcSEcCtD
Leucovorin—Abdominal pain—Prednisone—systemic scleroderma	5.09e-05	0.00109	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—systemic scleroderma	4.79e-05	0.00102	CcSEcCtD
Leucovorin—Hypersensitivity—Prednisone—systemic scleroderma	4.74e-05	0.00101	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—systemic scleroderma	4.73e-05	0.00101	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—systemic scleroderma	4.67e-05	0.000998	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	4.64e-05	0.000991	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—systemic scleroderma	4.64e-05	0.00099	CcSEcCtD
Leucovorin—Asthenia—Prednisone—systemic scleroderma	4.62e-05	0.000986	CcSEcCtD
Leucovorin—Pruritus—Prednisone—systemic scleroderma	4.55e-05	0.000972	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—systemic scleroderma	4.43e-05	0.000946	CcSEcCtD
Leucovorin—Diarrhoea—Prednisone—systemic scleroderma	4.4e-05	0.00094	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.4e-05	0.000939	CcSEcCtD
Leucovorin—Urticaria—Methotrexate—systemic scleroderma	4.27e-05	0.000912	CcSEcCtD
Leucovorin—Dizziness—Prednisone—systemic scleroderma	4.25e-05	0.000908	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—systemic scleroderma	4.25e-05	0.000908	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—systemic scleroderma	4.25e-05	0.000908	CcSEcCtD
Leucovorin—Vomiting—Prednisone—systemic scleroderma	4.09e-05	0.000873	CcSEcCtD
Leucovorin—Rash—Prednisone—systemic scleroderma	4.06e-05	0.000866	CcSEcCtD
Leucovorin—Dermatitis—Prednisone—systemic scleroderma	4.05e-05	0.000865	CcSEcCtD
Leucovorin—Hypersensitivity—Methotrexate—systemic scleroderma	3.96e-05	0.000846	CcSEcCtD
Leucovorin—Asthenia—Methotrexate—systemic scleroderma	3.86e-05	0.000824	CcSEcCtD
Leucovorin—Nausea—Prednisone—systemic scleroderma	3.82e-05	0.000816	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—systemic scleroderma	3.8e-05	0.000812	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—systemic scleroderma	3.68e-05	0.000785	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—systemic scleroderma	3.56e-05	0.000759	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—systemic scleroderma	3.42e-05	0.00073	CcSEcCtD
Leucovorin—Rash—Methotrexate—systemic scleroderma	3.39e-05	0.000724	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—systemic scleroderma	3.39e-05	0.000723	CcSEcCtD
Leucovorin—Nausea—Methotrexate—systemic scleroderma	3.19e-05	0.000682	CcSEcCtD
